{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative directly modifying a risk-adjective as defined in Q1.", "method": "llm_batch", "batch_id": "batch_1_16488", "batch_size": 260, "batch_pos": 162, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment does not contain high-potency verbs, potent metaphors, superlative negative nouns, or critical alert phrases.", "method": "llm_batch", "batch_id": "batch_2_16956", "batch_size": 260, "batch_pos": 162, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "The segment discusses potential future manufacturing ('will be able to manufacture'), not realised impact with a moderate verb + scale.", "method": "llm_batch", "batch_id": "batch_3_18272", "batch_size": 260, "batch_pos": 145, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment contains a statement about manufacturing capacity, but no loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_12464", "batch_size": 260, "batch_pos": 140, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "The segment reports uncertainty about manufacturing quantity and does not contain an explicit calming cue.", "method": "llm_batch", "batch_id": "batch_5_14396", "batch_size": 260, "batch_pos": 139, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "No minimiser or scale contrast found.", "method": "llm_batch", "batch_id": "batch_6_11932", "batch_size": 260, "batch_pos": 130, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_14808", "batch_size": 260, "batch_pos": 128, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "States uncertainty about future manufacturing capacity ('too early to tell how many doses... will be able to manufacture').", "method": "llm_batch", "batch_id": "batch_8_13156", "batch_size": 260, "batch_pos": 107, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
